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ABSTRACT

Introduction The prevalence of obesity is increasing in all segments of the population.
While excess body mass is associated with increased disease risks, the magnitude of the
risks are unclear from existing studies. In this dissertation we examine the association
between BMI and cardiovascular outcomes, CHD, stroke and CVD mortality and blood
pressure in four gender-race subgroups.
Methods

This study uses Black Pooling Project data which includes subject level data

on 27,691 men and women and 450,962 person-years of follow-up. Analysis includes
linear regression and Cox Proportional Hazard models and is gender-race specific.
Subject-level meta-analysis is used to obtain overall estimates of effect.
Results:

As a group, blacks have a higher adjusted mean systolic blood pressure than

whites and are classified as hypertensive at all BMI categories whereas in whites blood
pressure did not reach the hypertensive range until a BMI of at least 31 kg/m 2 . The ageadjusted rise in blood pressure for a BMI increase of25-30 kg/m 2 , is greater for white
than black women (5.9±0.2 vs. 4.4±0.5 p=0.005) and for white than black men (6.0±0.3
vs. 4.3±0.7 p=0.03). The adjusted relative risks for CHD, stroke and CVD mortality is
significant for obesity in whites but not in blacks. In obese whites, the relative risk for
C\lD mortality is (1.59[l.20-2.09]) in women <60 years and (1.21 [1.04-1.41]) in women

>60 years. There are no such significant associations for black women.
Conclusions Obesity has a greater impact on blood pressure and CHD, stroke and CVD
mortality in whites than blacks. While obesity prevention and treatment are
recommended for all, these findings suggest that these efforts will have a greater impact
on lowering blood pressure and reducing cardiovascular mortality in whites than blacks.

IV

CHAPTERl
Introduction

The prevalence of overweight and obesity is increasing in men and women of all
races/ethnicities 1;2. However, compared to whites, blacks have a higher prevalence of
cardiovascular risk factors including obesity and hypertension. 3 ;4 While obesity-related
health risks are similar in all populations the risk associated with a given amount of
excess weight may vary with race, gender and age. 5
The purpose of this dissertation is to examine the racial disparities in the
association between body mass index (BMI) and blood pressure and between BMI and
stroke, coronary heart disease (CHD), and cardiovascular disease (CVD) mortality
separately in men and women.
Chapter 1 is comprised of a brief introduction to the dissertation, specific aims
and an expanded review of the literature to provide additional background information.
In Chapter 2, we examine the association between BMI and blood pressure in black and
white men and women. In Chapter 3, we look at the association between BMI and
coronary heart disease (CHD), stroke and total cardiovascular disease (CVD) mortality in
black and white men and women. In Chapter 4, we consider the effect of age on the
association between BMI and CVD mortality in black and white women. Chapter 5
provides an overall summary of the findings in this dissertation.

1

Specific Aims

1. To assess the racial differences in the association between body mass index
and blood pressure in men and women.

2. To assess the racial differences of stroke, CHD and CVD mortality risks
associated with body mass index in men and women.

3. To calculate the age-specific stroke, CHD and CVD mortality risk associated
with body mass index in younger and older black and white women. '
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Review of the Literature
Cardiovascular Disease

Cardiovascular disease (CVD), principally coronary heart disease (CHD) and
stroke, accounted for 38.5% of all deaths in the United States in 2001 and has been the
number one killer in the United States for every year except 1918 since 19006 . In 2001,
the overall age-adjusted death rate from CVD was 329.6/100,000. For the four genderracial groups the CVD death rates were: 384.3 white men, 273.6 white women, 510.5
black men and 376.6 black women. Despite declines in death rates from CVD, the actual
number of deaths is increasing and the disparity between the four gender-racial groups is
changing.
Historically, CI-ID mortality rates were greater in whites than blacks but since
1980 the rates of CI-ID have been declining faster in whites. In 1989, the age-adjusted
CI-ID mortality rates "crossed over" and the rates for black men began to exceed the rates
for white lIlen 7 • Concurrently, the CHD mortality rates were 30% greater in black
women than white women. CHD mortality also occurs earlier in life for blacks than
whites. Before age 50, black men and women have a 50% and 100% higher death rate
than whites, respectively. After the age of 60 another crossover occurs and mortality
rates in blacks fall below that of whites. In 1995, the heart disease death rate was 29%
higher tor black than white men 8 and 40~/o higher in black than white women9 .
Similar patterns are evident in stroke mortality. Stroke death rates declined
substantially in the 1970s and 80s but little in the 1990s for all gender-racial groups 10. In
1998, stroke death rates were 1.4 times higher in black men and \vomen than in
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respective white gender groups and among blacks 490/0 of strokes occurred before age 75
compared to only 25% in whites.
The epidemic of heart disease and stroke can be expected to continue, with
widening disparities and an increasing burden, primarily from the aging population 11. In
1994, the working group on research in Coronary Heart Disease in blacks noted, "On one
hand, investigators have acquired a rich and detailed understanding of the general
relationships linking risk factors to CHD, and these relationships appear to be universally
applicable. On the other hand, data from specific ethnic subpopulations are inconsistent
in important aspects with certain findings in white men,,7. The limited availability of data
for the black population makes it difficult to determine whether these inconsistencies are
due to chance, reporting artifacts, or biological facts.

Body Mass Index (BMI) and Obesity
Body Mass Index (BMI), which represents the ratio of body weight divided by
height squared (kg/m2), provides an overall measure of adiposity. The CDC states that
"calculating BMI is one of the best methods for population assessment of overweight and
obesity. It is low-cost and easy to use for clinicians and the general public". While other
rneasures looking at body-fat distribution, such as waist circumference 12 ;13 may provide a
more thorough picture of obesity, BMI is easily and regularly obtained in clinical practice
and thus a readily available resource to use. BMI classifies weight into the following
categories.
Underweight
Normal Weight
Overweight
Obese

< 18.5 kg/m2
18.5-24.9 kg/m2
25.0-29.9 kg/m2
> 30 kg/m2
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The prevalence of overweight and obese is increasing in all segments of the
population. Over a 1O-year period, 1991-2001, the percent of obese (BMI >= 30) persons
increased dramatically. In the overall population, obesity increased from 120/0 in 1991 to
20.9% in 2001, which reflects an increase of61 percent. In men and women, these
percentages were 11.70/0 and 12.20/0 in 1991 and 210/0 and 20.8% in 2001, respectively.
Among whites and blacks, the differences in the prevalence are much more pronounced
with 11.3% and 19.3% in 1991 and 19.60/0 and 31.1 % in 2001 2, Similar evidence of the
obesity epidemic was found using NHANES data which uses measured data rather than
self-report l , In NHANES III, the age-adjusted prevalence of overweight and obesity
were 55.9% and 22.90/0, In 1999-2000 the age-adjusted prevalence increased to 64.5%
overweight and 30.5% obese. There was also a significant increase in extreme obesity
(BMI>40kg/m2) from 2.9% to 4.7%. In men there was little racial difference in the
prevalence of overweight and obesity, however in women overweight and obesity was
highest in black women.
In most recent estimates using NHANES data from 2003-2004, 66% of US adults
were overweight or obese (Brvl1 >25 kg/m2), 32% were obese (BMI >30 kg/m2) and 5%
were morbidly obese (BMI >40 kg/m2)14, The prevalence of overweight and obesity
varied with age, and race. Overweight and obesity was greater in middle-age (40-59
years) men and women than in younger (20-40 years) and older (>60 years) men and
women. The prevalence of overweight and obesity was also greater in black than white
women in all age groups. Among men, the prevalence of overweight and obesity was
similar for blacks and whites vvith white men having a greater prevalence of overweight
or obesity and black men having a greater prevalence of obesity and morbid obesity,
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Race, Body Mass and Mortality

Data from a large subject-level meta-analysis suggests that obesity is associated
with excess mortality whereas among overweight persons there was little evidence of
increased risk 15 • However, this relationship between body mass and mortality differs
among races. The body mass-related increase in risk begins at a 1 to 3 kg/m2 higher BMI
for blacks than whites 5 . In NHANESINHIS, the lowest mortality was associated with a
BMI of 27.1/30.2 kg/m2 for black men, 26.8/26.4 kg/m2 for black women, compared with
24.8/27.1 kg/m2 and 24.3/25.6 kg/m2 for white men and women 16 . Obesity is also
believed to have a profound effect on life span especially in younger adults 17. In a study
that calculated years of life lost

(YLL)~

the BMI associated with the least YLL or greatest

longevity was approximately 23-25 kg/m2 in whites and 23-30 kg/m2 in blacks 17 .<
A significant interaction was found to exist between ethnicity and BMI for all-

cause and CVD mortality 18. The increased risk of death associated with a high BMI has
consistently been shown to be stronger in whites than blacksI8~19.

Among persons who

had never smoked and had no history of disease in the Cancer Prevention Study II, the
relative risk of death from all causes for those at the highest BMI level was 2.58 in white
men and 2.00 in white women. In black

men~

the relative risk was 1.35 and not

statistically significant and in black women there was only small (20 to 30% ) nonsignificant increase in risk which was only found at the highest levels of BMI(> 35) 19. In
the Cancer Prevention Study I, the impact of BMI on mortality was modified by
educational status in black women. However, among women of the same education level
BMI had a greater effect on mortality in whites than blacks.
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Yet, other studies conclude that the BMI -all cause mortality association is similar
in blacks and whites 20 and others have found no association at a1l 21 .

Blood Pressure and Hypertension

Blood pressure classification, management and therapy guidelines are provided in
the following table from the seventh edition of the Joint National Committee on
Prevention, Detection, Evaluation and Treatment of High Blood Pressure(JNC7)22.
TabJe 1. Cld,>sillC:auon and Man.lgement of Blood Pressure for Adults. Aged 18 Years or Older
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Hypertension affects approximately 50 million individuals in the United States with the
prevalence expected to continue to increase as the population ages. Hypertension is
associated with atheroschlerosis, peripheral arterial disease, cerebrovascular accidents,
CHD, congestive heart failure, chronic renal insufficiency and failure, dementia and

death 23 . It is estimated that cardiovascular risk increases proportionally to blood pressure
increases above 115/85 mmHg24 emphasizing the importance of adequate blood pressure
managenlent.

flypertension and Body Mass
Body mass has long been recognized as a major predictor of blood pressure5~22;2531

but the exact nature of this relationship is unclear27 . INTERSAL T found that on
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average a 10 kg (22Ib) difference in body weight was associated a 3.0 mmHg difference
in systolic blood pressure and a 2.2 mmHg difference in diastolic blood pressure32 . In the
Framingham Heart Study, the relative risk of hypertension in men and women was 1.5 to
1.7 in overweight and 2.2 to 2.6 in obese 3]. A large scale study of young adults found
blood pressure to be highly correlated with BMI in both genders33. They also found that
while blood pressure was higher in men, as BMI increased the differences in blood
pressure between men and women diminished suggesting that the impact of obesity on
hypertension is more prominent in women. In ARIC, despite the increase in hypertension
associated with increases in BMI in both genders and races, the interaction between race
and BMI was only significant among women and among these women the odds of
hypertension were greater for white women34 . In the elderly, BMI was significantly
associated with hypertension in all gender-racial groups except black women35 .
The relationship between hypertension and body size was also examined In the
South Carolina Cardiovascular Disease Prevention Project to address the question "Are
the black-white differences in the prevalence of hypertension due to the differences in
associated body size?" In this study the investigators concluded that just some of the race
differences in hypertension prevalence are due to the effects of BMI and waist-to-hip
ratio (WHR). And that

~'the

racial discrepancies in BMI and WHR associations with

blood pressure suggest a different mechanism of hypertension for black and whites as
well as men and women".25
Despite similar obesity-related health risks in all populations, the specific level of
risk associated with a given level of excess weight may vary with race/ethnicity, age and
gender. For instance, the prevalence of hypertension in obese versus non-obese
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populations varies between races/ethnicities 5 . Data from ARIC showed that obesity was
associated with increased odds of hypertension in both blacks and whites but that the
odds ratios were much smaller in black women than white women34 .
Weight loss and management appears to be an effective method for primary
hypertension prevention and blood pressure lowering and is included as a strategy for
blood pressure control in the seventh edition of the Joint National Committee on
Prevention, Detection, Evaluation and Treatment of High Blood Pressure(JNC7)22. In
obese hypertensives weight loss, even modest weight loss, has been shown to be the most
effective non-pharmacological treatment approach36 . A meta-analysis of twenty-five
randomized controlled trials found that a weight loss of 1 kg ( 2.2 lbs) reduced systolic
and diastolic blood pressure by 1.5 and 0.92mmlHg26 . In the Trials of Hypertension
Prevention II, overweight men and women without hypertension who lost 4.5 kg after 6
months of treatment and maintained their weight loss for 30 months had a relative risk of
hypertension of 0.35 37 , Life expectancy based on a Markov model of cardiovascular
events found that initial blood pressure did not affect the magnitude of life expectancy for
equivalent blood pressure reductions 38 ,
Obesity as a Predictive Risk Factor
Obesity-related health risks are similar in all populations but the exact level of
risk associated with a given amount of excess weight may vary with race, ethnicity,
gender, age and societal conditions 5 . The major independent risk factors, as typically
used by Framingham, for CI-ID prediction include: blood pressure, total cholesterol, HDL
cholesterol, current smoking, diabetes and age 39 . Obesity had been considered a
predisposing risk factor, or a factor that worsens the major independent risk factors 40 ,
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However, a growing body of literature suggests that obesity is not only related to but
independently predicts CVD 19;4 1;42 and coronary atheroschlerosis for both men and
women with minimal increases in BMI43 -4s . However, results in literature remain
inconsistent. Some studies have found an association between BMI and CHD mortality
in white men and women31 ;46;47, in white, but not black women48 , and in only white
women of lower socio-economic status 49 . In the combined Charleston Heart Study and
Evans County Heart Study dataset, a higher BMI was found to have little effect (RR=
0.97 (0.94-0.99)) on white men and weakly (RR = 1.05 (1.01-1.10)) but significantly
associated with CHD mortality in black menso.
Obesity is listed as a potentially modifiable risk for stroke in the American Heart
Association guidelines 51 . Some studies have found weight to be independently associated
with stroke 41 , others describe the relationship between stroke and BMI to be~ although
lower in absolute terms. similar to that ofCHD for men but less pronounced in women46
and others suggest that risk decreases with age S2 . In the Physicians' Health Study the risk
of stroke was found to be associated with increased BMI and the risk remained after
adjusting for potential biological mediators, such as hypertension and diabetes s3 . The
authors note that hypertension and diabetes accounted for much, but not all, of the
increased risk. In the Nurses' Health Study, obesity was found to be an important risk
factor for ischemic and total stroke but not hemorrhagic stroke 54 . Others concluded no
association between weight and stroke 5S - S8 or that in the presence of other cardiovascular
risk factors adiposity was not independently associated with stroke 59 .
Total CVD mortality has also been associated with weight41 . Some studies have
found that the risk of CVD death is associated with a high BMI and that the risk is greater
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for whites than blacks 19 • The Chicago Heart Association Detection Project in Industry
Study examined the long-term consequences of obesity and found an independent, direct
positive association with CVD mortality even after controlling for variables in the causal
pathway6o. The Framingham Heart Study found that after 26 years of follow-up each
standard deviation increase in relative weight was associated with an increase in
cardiovascular events of 15% in men and 22% in women61 .
Various literature has also found that risk factors tend to cluster and that the
clustering worsens with weight gain 62 ;63. There appears to be a biologically plausible
metabolic basis for risk factors to be affected by weight and weight gain. All elements of
the cardiovascular risk profile are worsened by involuntary weight gain, including
dyslipidemia, hypertension, insulin-resistant glucose intolerance, left-ventricular,
hypertrophy, hyperuricemia and elevated fibrinogen 61 • The following schematic displays
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Age, Body Mass and Mortality

Age is another factor that has an effect on the association between body mass and
stroke/CHD/CvTD mortality. i\ recent article that attempted to quantify the effect of
obesity by calculating years of life lost stated that obesity has a profound effect on
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lifespan 17 , The usual J- or U-shaped curve was observed between BMI and years of life
lost, with the leanest and heaviest at greatest risk. However in blacks, decreases in life
expectancy were not observed until a BMI of 37 or 38kg/m2 in women and 32 to 33
kg/m2 in men suggesting that body mass is not as detrimental in the black population. The
Framingham Offspring study confirms that BMI is strongly related to age. Men reached
a BMI plateau around age 50 whereas women experienced a constant increase in BMI
with age until age 70 65 . The age at which BMI peaks and weight loss begins varies with
race and gend er66.
Analysis of the American Cancer Society's Cancer Prevention Study data
including 62,116 men and 262,019 women suggests that among men and women aged
30-74 years an increased mortality risk from CVD and all causes is associated with a

greater body weight, however the relative risk associated with excess weight is greater in
younger persons 67 . In a historical cohort of men with a mean follow-up of 35 years, a
strong significant association was found between BMI in young adulthood and CVD
mortality (HR 2.41) and a weaker, non-significant association in mid-adulthood (HR
1.33)68. i\.nd in a prospective cohort study of obese persons referred to an obesity clinic

the risk of death increased with body weight but obesity-related excess mortality declined
with age at all levels of 0 besity 69. On the contrary, in older Finnish women, mortality
varied little with BMI 70 and in men the risks were similar for the heaviest and leanest
Inen and greatest for those under age 75 71 . In the combined ARIC and CHS dataset, there
was little evidence in IMT difference, a measure of atherosclerosis, for BMI and
hypertension in whites and blacks across age strata72 .
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The suggestion that body mass affects people differently is not a novel idea.
There has long been discussion that the ideal weight for elderly persons should be greater
than younger persons 73. In an older cohort (average age 79) being heavier than
recommended was associated with lower short-term mortality, whereas being overweight
at younger ages was associated with increased mortality 74. In the Longitudinal Study of
Aging, obesity in older participants was associated with reduced mortality compared to
those who were normal weight 75 , and in a cohort of 70 year olds, the lowest risk for 15year mortality was found in those with higher BMI76.
Other research has shown that after age 60 the prevalence of obesity decreases 77.
The authors suggest a few explanations for this phenomenon including selective survival,
where obese young and middle-aged persons die prematurely; cohort effect, where older
persons come from cohorts that typically were not obese or that body fat is redistributed
with increasing age hence BMI is not an optimal measure of body composition. However
it is also noted that while obesity declines, fat storage is still common in the elderly,
progressively more fat is stored in the abdominal cavity and that the weight loss
commonly seen in the elderly is related to a loss of lean body mass.

]3

Black Pooling Project
The Black Pooling Project consists of four studies (Charleston Heart Study, Evans
County Heart Study, N;HANES I and NHANES II) and includes subject-level data on
2,843 black women, 2,010 black men, 12,739 white women and 10,089 white men.
Characteristics of each study in the Black Pooling Project are noted for each gender-race
group below:
BLACK FEMALES
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Study Summary

Charleston Heart Study
The Charleston Heart study is a population-based prospective cohort study
including 2,181 (653 white men, 741 white women, 333 black men and 454 black
women) participants aged 35 and older representing 84% of the population-based
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sampling plan78~79 in 1960. The study was supplemented with 102 high-SES black men
recruited by peer nomination in 1964 when the random sampling was found to include
only a few participants in this class. In 1960 the response rates were 8S% of white men,
85.8% of white women, 78.3% of black men, and 84.1 % of black women and in 1964

900/0 of the high-SES black men 80. Throughout the years, periodic searches of death
certificates at local health departments were made. The Charleston Heart study includes

30 years of follow-up and in 1990 the vital status of 980/0 of whites and 99% of blacks
was known.
Body mass index, smoking status and diabetes status were all collected based on
medical history 78. Blood pressure was measured in the seated position and serum
cholesterol level was determined by the direct cholesterol method by Zlatkis. The cause
of death was obtained from nosologists' coding of underlying cause of death on death
certificates. Death certificates from the period of 1960-67 (which used codes from leD
seventh edition) were recoded to

leo eighth edition.

Evans County Heart Study
The Evans County Heart study is a community-based closed cohort including all
black and white residents over the age of 40 and a SO% sampling of those aged IS to 3S.
In 1960, 3,102 persons or 92% of all eligible participants were in the study including
94% of white men, 92% of white ",,'omen, 90% of black men and 94% of black

wonlen 49 ;81. In 1990, after 30 years of follow-up, the vital status was known for
approxiInately 980/0 of the participants.
A complete and detailed medical history was obtaIned on each participant which

includes details on past and present smoking 82 . During the physical exam., three seated
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blood pressures were taken on the left

arm~

the first at arrival to the clinic, the second 30

to 60 minutes later, and the third, 15 to 20 minutes after the first. Serum cholesterol was
measured with the Abell-Kendall method. A complete tracing of all information
pertaining to the circumstances and cause of death were gathered. This included copies
of death certificates, autopsy reports, hospital and physician records, newspaper
obituaries, and descriptions by relatives present at time of death. The information was
reviewed by a panel consisting of three physicians and a cardiologist. A neurologist
independently reviewed all deaths for any evidence of stroke. Criteria were established
prior to review to classify a death.
NHANES I Epidemiologic Follow-up Study
NHANES I is a probability sample of the civilian, non-institutionalized United
States population. The baseline survey consisted of 20,749 persons aged 1 to 74 years
from 1971 to 1975. Follow-up studies were conducted from 1982 to 1984, in 1986, 1987
and in 1992 on 14,407 persons or their proxies who were 25 to 74 years of age at
baseline. Among persons aged 30 to 74 years, there were 10,132 white and 1,835 black
participants. In 1993, after 20 years of follow-up, 96.20/0 of the original cohort has been
successfully traced. Cause of death was determined from death certificates in each
study.83-85
NHANES II Mortality Study
NHANES II is a probability sample of the civilian, non-institutionalized United States
population. The baseline survey, conducted from 1976 to 1980, consisted of 20,322
persons aged 6 months to 74 years. Mortality follow-up through matching with the
National Death Index database for 1979 to 1992 and through the Social Security
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Administration's Mortality Tapes Matching System for 1976 to 1988 was conducted for
the 9,252 participants aged 30 years or older. Among participants aged 30-74 years at
baseline there were 8,080 white and 997 blacks. Follow-up lasted for 15 years. Cause of
death was ascertained solely by computerized matching to national databases and
evaluation of the resulting matches 83 ;85;86.

Methods

Subject-level Meta Analysis
The purpose of the subject-level meta-analysis is to derive a

~'pooled"

or

combined estimate of the effect. This provides a more sensitive analysis than typical
meta-analysis of the literature. The collection and reanalysis of individual data provides
a reliable means of addressing questions not satisfactorily resolved in individual studies 87 92.

This is accomplished by treating the data from the four studies as a single sample.

That is, for each study a model will be fit. Then the risk factor coefficients from the
regression in the individual studies will be combined to obtain a pooled coefficient. The
pooled coefficients will comprise the pooled risk equation for each gender-racial group.
The pooled estimates are NOT obtained by merging all participants into a single study.
To obtain the pooled estimates, either a fixed effects or random effects model will
be used. If the effects are homogenous (do not reject the null) among the studies, we use·
a fixed effects model to obtain the pooled estimate. If there is a significant heterogeneity
among the studies (reject the null), we use a random effects model 92 .
Homogeneity of the coefficients will be tested with the Q-statistic using the
following equation:
2

X k-J
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where Wi (= 1 / var(bD ) is the applied weight, b i the coefficient for the ith
study and B" is the fixed effects estimate of the pooled coefficient
(calculated below).

Fixed Effects Model calculation for pooled coefficient:
B"

= '"
~

As usual we use

W·I

b I. / '"
~

W·h

s? an estimator for a?

The variance of B" is obtained from the following

equation:
var(B") =

I w/

var(b i

)

/

(2: w;)2

1

/

I

Wi

Random Effects Model calculation for pooled coefficient:
B. .

*=

'"
b·I I'"
~ w·*
I
~ w·*
1,

with variance established using the following equation:

To estimate

2
O'b ,

the between-study component of variance, we derive a method of

moments estimate of ab 2 by equating

Ow to its expected value and solving the following

equation:

The max function in this equation assures us that the between-studies component of
variance is nonnegative.
The above methods will be used to build a pooled model for each gender-racial
group. It is possible that some effects are fixed effects while others are random effects,
and thus either B" or B"* will be used as the "pooled coefficient estimate" depending
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whether fixed or random is appropriate for each particular parameter.
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Abstract
Background: The linear association between body mass index (BMI) and blood pressure
(BP) is well established. The association between BMI and BP may vary by race, which
has important implications for lifestyle measures to prevent and treat hypertension. This
study examines the association between BMI and BP in black and white women and men.
Methods: This study uses Black Pooling Project data. The average age-adjusted rises in
BP associated with increasing BMI were calculated separately for each for each genderrace group. Racial differences were tested with a Z-statistic.
Results: As a group, blacks have a higher adjusted mean systolic BP than whites and are
classified as hypertensive at all BMI categories. In contrast, mean systolic BP did not
reach the hypertensive range in whites as a group until a BMI of at least 31 kg/m:. The
greatest disparity in BP between blacks and whites was seen in normal weight subjects
(15mmHg) and group differences declined to 10 mmHg in the obese. With a BMI
increase from 25-JO kg/m 2 , the age-adjusted rise in BP was greater for white than black
women (5.9±O.2 vs. 4.4±O.5 p=0.005) and for white than black men (6.0±0.3 vs. 4.3±O.7
p=O.03).
Conclusions: Increasing BMI has a greater impact on BP in whites than blacks. BP,
among lean blacks as a group, is in the hypertensive range and suggests that factors other
than BMI contribute to their elevated blood pressures. The data suggest that weight loss
may be less effective for lowering BP in blacks than whites.
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Introduction
The linear association between body mass and blood pressure has long been
recognized( 1-11). Blood pressures are on average higher in overweight and obese
persons. Likewise, weight loss has been associated with reduction in blood
pressure(2; 12-14) which has prompted the Seventh Joint National Committee on
Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7) to
recommend weight reduction and management as strategies for high blood pressure
control. It is estimated that a 10 kg weight loss is associated with a 5-20 mmlHg
reduction in systolic blood pressure( 4).
The association between body mass index and blood pressure may vary by
race( 1; 15) and gender, which has important implications for both the pathogenesis and
management of hypertension. The Atherosclerosis Risk in Communities (ARIC) study
showed that body mass index and fat patterning were associated with greater risk for
hypertension in all four gender-race subgroups including black and white men and
women. When comparing race groups by gender, obesity and central fat pattern were
associated with a greater risk for hypertension in white than in black women but did not
have a differential effect in black and white men(16). Our previous work also showed
that increased body Inass index and waist-to-hip ratio were associated with increased
blood pressure in black and white men and women( 1). Despite the significant association
of weight and fat pattern to blood pressure in all four gender-racial subgroups,
hypertension rates remained significantly greater in blacks than whites after adjusting for
body size and fat pattern. The racial difference in blood pressure persisted even after
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adjustment for body mass and fat distribution, which suggested that other factors played a
greater role in the pathogenesis of hypertension in blacks than whites.
The relationship of body mass index to hypertension has important implications
for informing lifestyle interventions to prevent and treat high blood pressure. Previous
studies suggest that body mass index has a smaller effect on blood pressure in blacks than
whites, particularly black than white women. Although both BMI and fat pattern are
related to blood pressure, height and weight, required to calculate BMI, are more readily
and commonly obtained in clinical settings. The current study uses the Black Pooling
Project database to more fully elucidate the impact of body mass index on blood pressure
in black and white women and men.

Methods

Data Source. This study uses Black Pooling Project data, which includes subjectlevel data from four studies; Evans County Heart Study, Charleston Heart Study,
NHANES I and NHANES II. The Project was established to provide an adequate
number of black men and women to assess cardiovascular disease risks. Baseline data on
27,691 persons (2,010 Black men, 2,843 Black women, 10,099 white men and 12,739
white women) were collected between 1960 and 1980. In each of the studies, blood
pressure~

total cholesterol, height and weight were measured and information on diabetes,

and smoking status were collected in a uniform manner by trained personnel(17-21).
Information on antihypertensive medications was obtained in NHANES I and II.
Information was not collected for antihypertensive medication usage in Evans County
Heart Study or Charleston Heart Study, which is reflective of the low frequency of
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hypertension treatment in the early 60's(17). Men and women who reported use of
antihypertensive medications were excluded from this analysis resulting in a sample size
of 24,606 persons (1,805 Black men, 2,422 Black women, 9,190 white men and 11,189
white women).
Analysis. Study characteristics for each gender-race group were calculated

according to weight categories (underweight, BMI <18.5 kg/m2, normal weight 18.524.9; overweight, BMI 25.0-29.9; and obese, BMI >30). The prevalence of JNe 7 blood
pressure categories (normal [SBP <120 mmHg and DBP <80 mmHg], pre-hypertension
[SBP 120-139 mmHg or DBP 80-89 mmHg} , hypertension stage 1 [SBP 140-159 mmHg
or DBP 90-99 mmHg], and hypertension stage 2 [SBP > 160 mmHg or DBP > 100
mmHg]) and the mean BMI according to blood pressure categories were also calculated
for each gender-race group.
Linear regression using continuous BMI, controlling for age, cholesterol,
diabetes, smoking status and cohort was used to calculate the average increase in systolic
blood pressure associated with an increase in BMI. Separate regressions were fit for each
gender-race group and the quadratic tenn, BMI2, was added to the model and included if
significant. The adjusted mean systolic blood pressure was calculated in each BMI
category for black and white women controlling for the mean values of age, cholesterol,
diabetes and smoking status. The changes in blood pressure from normal weight to obese
within each gender-race group as well as the racial differences within each weight
category were assessed. Adjusted mean systolic blood pressure was calculated for
thirteen categories of BMI controlling for the mean values of age, cholesterol, diabetes
and smoking status. All analyses were gender and race specific and were performed
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using SAS v9. O. Z-tests were used to determine whether a significant racial difference
was present for men or women in the average increase in systolic blood pressure and in
the mean blood pressure values associated with BM!.

Results
Descriptive information for our study population according to race, gender and
weight are presented in Table 1 and 2. The prevalence of overweight and obesity was
greater in black than white women and white than black men. Mean blood pressure
values were greater among blacks than whites in all weight categories. The mean systolic
and diastolic blood pressure increased with weight for both blacks and whites but more
strongly in whites. As expected, there was an inverse relationship between BMI and the
prevalence of current smoking.
The prevalence of blood pressure and mean BMI by JNC 7 category are shown in
Table 3. Normal blood pressure vvas more prevalent in whites than blacks. Among
whites, 28% of women and 15% of men were classified with normal blood pressure
compared to only 15% of black women and 90/0 of black men. Stage 1 and stage 2
hypertension were more prevalent in blacks than whites. Among blacks, 61 % of women
and 630/0 of men were classified with stage 1 or stage 2 hypertension compared to 35% of
white women and 450/0 of white men. As blood pressure increases, using the categories
of normal to stage 2 hypertension, the mean BMI also increases. While black women had
a greater BM! in all blood pressure categories, the increase in mean BMI was greater in
white women. In men, whites had a higher BMI than blacks in all blood pressure
categories, but the increases in BM! were similar for both black and white men.
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For each blood pressure outcome within each gender-race group, we fit one model
adjusting only for age and cohort, and we fit another model adjusting for age, total
cholesterol, diabetes, smoking status and cohort. For these models, the average increase
in systolic and diastolic blood pressure associated with an increase in BMI was greater
for whites (Table 4). This increase in systolic and diastolic blood pressure was
significantly greater for whites than blacks in both men and women in the age and cohort
adjusted analysis and the fully-adjusted analysis with the exception of adjusted diastolic
blood pressure for men.
Table 5 shows mean values for systolic BP by gender-race groups. The
differences of blood pressure within each BMI category as well as the differences in
blood pressure between BMI categories among each gender-race subgroups are of
interest. When examining the data within BMI category across gender-race groups,
alllong normal weight subjects, the racial difference was 18 mm Hg for women and 13
mm Hg for men. Among overweight subjects, the racial difference was 16 mm Hg for
women and 11 mm Hg for men. Among obese subjects, the racial difference was 15 mm
Hg for women and 7 mm Hg for men. When viewing the data across BMI categories
within the gender-race groups, the systolic BP difference between normal weight and
obese was 13 mm Hg for black women compared to 15 mm Hg for white women and 7
mm Hg for black men versus 13 mm Hg for white men.
Figure 1 presents the adjusted mean systolic blood pressure according to BMI for
each gender-race group controlling for mean values of age, cholesterol, diabetes and
smoking status. A linear pattern between BMI and blood pressure was observed for each
gender-race group but appears to be more pronounced in white than black men and
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women. Blacks have a higher adjusted mean blood pressure than whites and at all levels
of BMI blacks as a group would be classified as hypertensive. In contrast, mean blood
pressures did not reach the hypertensive range in whites as a group until a BMI of
approximately 31 kg/m2 in men and 33 kg/m2 in women.
A significant racial disparity in the association between BMI and adjusted mean
blood pressure is present for both men and women. The racial disparity in blood pressure
is greatest among leaner persons and narrows progressively with increasing degrees of
overweight and obesity until BMI exceeds ----38.5 kg/m2 (Figure 1).
Figure 2 shows the racial and gender-racial blood pressure differences within
weight categories. Racial disparities in blood pressure were greater in normal weight
than overweight and obese subjects. The racial disparity in systolic blood pressure
declined with increasing BMI category in both women and men, but racial differences in
blood pressure at each category of BMI were greater for women than men.
Discussion
The positive relationship between body mass index and blood pressure is well
documented (6;9; 11; 16;22;23). However, the association between BMI and blood
pressure within gender-race groups has not been explored in the detail, and typically with
fewer subjects than we have in our study. In our cross sectional study, there was a linear
association observed between BMI and blood pressure (Figure 1), which was steeper in
whites than blacks. On average, for each unit increase in BMI there is a greater increase
in blood pressure for whites than blacks. For example, a 5 unit increase in BMI, such as
an increase in BMI from 25 kg/m2 to 30 kg/m 2, was associated with an increase in
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systolic blood pressure of approximately 6 mmHg in white women and men and ---4.4 mm
Hg in black women and men.

Racial disparities in blood pressure were greater in normal weight than obese
subjects as shown in Figure 2. In fact, regardless of BMI, systolic blood pressures of
black women and men as a group were classified as hypertensive. In whites as a group,
blood pressures in the hypertensive range did not occur until a BMI of 33 kg/m2 for
women and 31 kg/m2 for men. While the racial disparity in systolic BP declined with
increasing BMI category in both women and men, the absolute racial differences in BP at
each category of BMI were greater for women than men. These findings suggest that
factors other than weight contribute to racial differences in blood pressure and that these
factors may be different and playing a greater role in women than men. However, these
other possible factors likely do not include age, cholesterol, diabetes or smoking status,
since we have adjusted for them in the regression models. These findings also raise the
possibility that weight loss is less likely to normalize blood pressure in blacks than
whites.
These findings confirm the strong association of weight and blood pressure
reported by others in previous studies(24). Our results also show that this association is
stronger in whites than blacks( 1; 16) suggesting that the higher prevalence of
hypertension in blacks might be due to factors other than weight. As noted previously,
the rise in systolic and diastolic blood pressure with increasing BMI was greater in whites
than blacks and the racial disparity was clinically and statistically significant. On the
contrary, our study did not find a gender difference in the increase in systolic and
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diastolic blood pressure associated with an increase in BMI which emphasizes the effect
of race on this association.
One of the limitations to this study is the lack of data on waist circumference.
Several studies have been done to identify potential mechanisms of obesity-associated
hypertension(22;25-27). Most of this work has focused on abdominal obesity(16).
Abdominal obesity, estimated using waist circumference, has been linked to hypertension
and cardiovascular disease(28-31). Data on waist circumference would have allowed a
more comprehensive analysis of the relationship between weight and blood pressure.
Nevertheless, the large sample size of this study provides a unique opportunity to
examine the association using BMI, which some have found to be highly correlated to
waist circumference (r----O.8-0.9)(16) Evidence suggests that waist circumferences at any
BMI are similar or less in blacks than whites (32;33). These observations further suggest

that racial differences in central body fat do not explain the higher pressures in blacks
than whites at all BMI levels or the reduction in racial differences with increasing BMI
categories . although differences in the ratio of visceral to subcutaneous abdominal fat
could playa role.
The large and diverse population of black men and women is one of this study'S
greatest strengths. Additionally, this study included white men and women from the
same populations that the black men and women were derived, which allowed
comparison of black and white men and women from the same geographic location.
While the association between obesity and hypertension is well-documented this
study indicates that increasing levels of body mass index have a greater impact on blood
pressure in \\-'hites than blacks. These data suggest that the higher blood pressures in
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blacks than whites are due to factors other than body mass, e.g., a higher set point for
renal pressure natriuresis(34) that is independent of weight. While maintenance of a
healthy weight is recommended for good general health, our findings raise the possibility
that weight loss may be less effective at lowering blood pressure in blacks than whites.
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Table 1. Gender-race specific percent distribution of BM!.
Black Women

N
Underweight (BMI<18.5 kglm 2)
2
Normal Weight (BMI 18.5-24.9 kglm )
(BMI 25-29.9 kg/m2)
Overweight
(BMI> 30 kg/m2)
Obese

2,422
4%
33%
31%
32%

White Women
11,189
4%
54%
26%
16%

Black Men
1,805
20/0
50%
34%
14%

White Men
9,190
2%
43%
43%
12%

Table 2. Selected characteristics of the four gender-race groups by BMI category.

UNDERWEIGHT

NORMAL WEIGHT

OVERWEIGHT

OBESE

N
Mean Age [sd]
Mean Cholesterol [sd]
Mean SBP [sd]
Mean DBP [sd]
Mean BMI [sd]
Diabetes %
Current Smoker %
N
Mean Age [sd]
Mean Cholesterol [sd]
Mean SBP [sd]
Mean DBP [sd]
Mean BMI [sd]
Diabetes %
Current Smoker %
N
Mean Age [sd]
Mean Cholesterol [sd]
Mean SBP [sd]
Mean DBP [sd]
Mean BMI [sd]
Diabetes %
Current Smoker %
N
Mean Age [sd]
Mean Cholesterol [sd]
Mean SBP [sd]
Mean DBP [sd]
Mean 8MI [sd]
Diabetes %
Current Smoker %

Black Women

White Women

101
48 [16]
212 [37]
137[32]
83 [16]
17.3[0.9]
6.0
34
788
47 [15]
214 [146]
142 [33]
87 [16]
22.1 [1.8]
3.1
35
757
49 [14]
224 [50]
147 [33]
89 [15]
27.5 [1.4]
6.8
27
776
49 [13]
225 [49]
157 [35]
96 [17J
35.2 [5.2]
6.7
23

52

White Men

453
46 [15]
207 [53]
121 [20]
75 [10]
17.4[1.0]
2.7
48
6,046
47 [14]
219 [40]
125 [21]
78 [10]
21.9[1.7]
2.0
33
2,930
52 [14]
234 [50]
135 [23]
83 [11]
27.1 [1.4]
3.7
25

Black Men
44
56 [16]
194 [36]
143 [30]
88[15]
17.5 [1.0]
0
68
901
52 [14]
206 [43]
145 [30]
90 [16]
22.2 [1.7]
3.0
60
608
51 [14]
221 [48]
147 [28]
92 [16]
27.2
5.0
46

1,760
51 [141
232 [52]
144 [25]
89 [121
34.4 [4.4]
6.1
20

252
52 [12]
231 [51]
151 [28]
96 [16]
33.6 [3.7]
8.7
37

1,078
51 [13]
226 [44]
144 [22]
91 [13]
32.8 [2.9]
5.5
33

203
57 [14]
200 [38]
130 [24]
79 [12]
17.4[1.0]
2.5
65
3,973
51 [15]
215 [43]
131 [20]
82 [11]
22.6 [1.7]
3.1
47
3,936
52 [14]
225 [45]
136[19]
86 [11]
27.1 [1.4]
3.6
37

Table 3. Prevalence of JNe 7 BP category (top) and mean [SD] BMI values (bottom).
Black Women
Normal
Pre-Hypertension
Stage 1 Hypertension
Stage 2 Hypertension
Normal
Pre-Hypertension
Stage 1 Hypertension
Stage 2 Hypertension

15%
240/0
230/0
380/0
24.7
27.0
28.2
29.2

White Women
280/0
37%
210/0
140/0

[5.0]
[5.6]
[5.8]
[7.4]

22.8
24.8
26.6
28.4

[3.5]
[4.7]
[5.4]
[6.4]

Black Men
9%
280/0
290/0
340/0

White Men
150/0
400/0
280/0
170/0

23.4
25.0
25.6
26.0

23.8
25.2
26.3
27.0

[3.6]
[4.2]
[4.4]
[4.8]

[3.3]
[3.4]
[4.0]
[4.5]

Pre-Hypertension: SBP 120-139 mmHg or DBP 80-89

* Normal: SBP <120 mmHg and DBP <80 mmHg
mmHg
Stage 1 Hypertension: SBP 140-159 mmHg or DBP 90-99 mmHg

Stage 2 Hypertension: SBP 2:160 mmHg or DBP 2:100

mmHg

Table 4. Blood pressure increase [SE] associated with a BMI increase from 25 kg/m2 to

30 kg/m2
++

p-value

White Men

0.005

4.3 [0.7]

6.0+ [OJ]

0.03

4.0+ [0.1]

0,0005

3.4 [0.4]

0.008

5.7+ [0.2]

0.02

4.2 [0.7]

4.5 [0.1]
5.9+ [OJ]

3.9+ [0.1]

0.002

3.6 [0.4]

4.4+ [0.2]

0.07

White Women

SBP*

4.4+ [0.5]

5.9+ [0.2]

DBP*

2.9+ [0.3]

SBP**

4.4+ [0.5]
2.9~ [0.3]

DBP**

p-value

Black Men

Black Women

*age and cohort adjusted

+quadratic term (BMI2) included in the regression

**age, cholesterol, smoking, diabetes and cohort adjusted

++p-value testing for BP equality in blacks and whites by gender

53

0.03

++

Table 5. Adjusted mean systolic blood pressure values and blood pressure difference by
BMI category.
Black Women
Underweight
Normal Weight
Overweight
Obese
~ Obese - Normal Weight

White Women Black Men

138
145
148
157
12

124
127
132
142
15

*adjusted for mean values of age, cholesterol, diabetes and smoking status

54

139
143
146
150
7

White Men

131
130
135
143
13

Figure 1. Adjusted mean systolic blood pressure by BMI.
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Figure 2. Blood Pressure Differences among Blacks and Whites within Weight
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Abstract

The relationship between BMI and CHD, stroke and CVD mortality is unclear,
particularly among blacks. To address this gap in the literature, we used The Black
Pooling Project database which includes 27,691 blacks and whites who were followed for
15-30 years. The adjusted relative risks for CHD, stroke and total CVD mortality were
estimated using subject-level meta-analysis. The results showed that obesity increased the
adjusted relative risks for CHD, stroke and CVD mortality in whites but not in blacks.
While obesity prevention and treatment are recommended for all, the findings suggest
these efforts will have a greater impact on reducing CVD mortality in whites than blacks.
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Introduction
A growing body of literature suggests that obesity is not only related toe 1) but
independently predicts cardiovascular disease (CVD) for both men and women(2-4).
Evidence also indicates that minimal increases in BMI are associated with increased
CVD risk( 5 ;6).

Despite the relationship between weight and cardiovascular risk factors,

the association between body mass index and coronary heart disease (CHD), stroke, and
CVD mortality remain inconsistent in various epidemiological studies.

One line of evidence indicates that total CVD mortality is associated with
weight(3), that the risk is greater in whites than blacks(2) and that an increased(7) risk
remains even after controlling for weight-related risk factors including hypertension,
hyperlipidemia and diabetes(8). Results from several studies suggest a. variable
association between BMI and CHD mortality in white men and women,(9-11) in white,
but not black women,(12) in only white women of lower socioeconomic status(13) and in
black but not white men(14).
The literature also indicates a variable relationship between weight and stroke
mortality.

One study reported that weight was independently associated with stroke

mortality,(3; 15)

whereas

another

found

that

this

relationship

was

no

longer

significant( 16) after adjusting for potential biological mediators. Other reports suggested
that the association depends on the type of stroke( 17) is less pronounced in

women~( 10)

or that there is no association( 18-21).
Despite a higher prevalence of obesity(22) and cardiovascular events in the black
than white population,(23-25) studies examining the association between body mass and
mortality in blacks and whites have typically found the mortality risk associated with
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body mass to be greater in whites(2;26).

The body mass-related increase in risk is

suggested to begin at a 1 to 3 kg/m 2 higher BMI for blacks than whites(27).
One of the factors limiting a more definitive assessment of a differential
relationship of weight to CVD mortality in blacks and whites is the relative paucity of
data on black men and women. To address this limitation, the current study examines the
relationship between body mass index and CHD, stroke, and CVD mortality in a large
population of black and white men and women from the Black Pooling Project who were
followed up for 15 to 30 years.

Methods
Data Source.

This study uses data from the Black Pooling Project. The Black

Pooling Project, which includes subject-level data from four studies; Evans County Heart
Study, Charleston Heart Study, NHANES I and NHANES II, was established to provide
an adequate number of black men and women to assess cardiovascular disease risks.
Baseline data on 27,691 persons (2,010 Black men, 2,843 Black women, 10,099 white
men and 12,739 white women) were collected between 1960 and 1980.
In each of the studies, baseline values of blood pressure, cholesterol, height,
weight, diabetes status and smoking status were measured or gathered in a uniform
manner by trained personnel(13;14;28-30).

Cause of death was determined from death

certificates in each study (14;28-31) except NHANES II in vvhich mortality status was
ascertained solely by computerized matching to national databases and evaluation of the
resulting matches(32). In addition to death certificates, all information gathered in the
Evans County Heart Study pertaining to death was reviewed by a panel of three
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physicians and a cardiologist to classify the deaths.

A neurologist also reviewed the

information for evidence of stroke(29).
Analysis. Sample size, number of CHD, stroke, and CVD deaths, number of

contributing person-years, and the mean and prevalence of study characteristics were
calculated for each race and gender-race group. All patient characteristics used as
covariates in the models are baseline characteristics
The relative risk of CHD, stroke, and CVD mortality associated with underweight
(BMI <18.5 kg/m2), overweight (BMI 25.0-29.9 kg/m2) and obese (BMI >30 kg/m2)
using normal weight (BMI 18.5-24.9 kg/m2) as the referent group was calculated using a
Cox Proportional Hazard Model. Three models were evaluated. The covariates in each
of the three models were chosen a priori. The first model (Model 1) was adjusted for age,
the second (Model 2) was adjusted for age and smoking status, and the third (Model 3)
was adjusted for age, hypertension, cholesterol, diabetes and smoking status.

These

models were run for each race group (black and white) and each gender-race group (black
and white women and men) separately in each of the four cohorts and then pooled using
meta-analysis to obtain an overall estimate.

Differences between blacks and whites for

the effect of BMI category on CHD, stroke, and CVD mortality were tested by comparing
the regression coefficients for BMI category using a Z-statistic in men and women.
An overall estimate of the effect was obtained using subject-level meta-analysis.
The collection and reanalysis of subject-level data provides a .reliable means of
addressing questions not satisfactorily resolved in individual studies(33-38)and is a more
sensitive analysis than typical meta-analysis of the literature. This is accomplished by
treating the data from the four studies as a single sample. That is, for each study a model
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will be fit for each race group and each gender-race group.

Then the risk factor

coefficients from the regression in each race group or each gender-race group for the four
individual studies will be combined to obtain a pooled coefficient.

The pooled

coefficients will comprise the pooled risk equation for each race group or each genderrace group. Both fixed and random effects models for the study effect were used. Since
the results from the fixed effects model were generally consistent with the results from
the random effects model, only the results from the fixed effect model are reported.

Results
Descriptive information for our study population according to race and genderrace group is presented in Table 1. Mean blood pressure values and the prevalence of
obesity, diabetes, and current smoking status were greater among blacks than whites,
whereas mean cholesterol values were greater for whites.
The age-adjusted (Modell), age and smoking adjusted (Model 2), and age,
cholesterol, diabetes, hypertension and smoking adjusted (Model 3) effects of overweight
and obesity on relative risk

[95~/o

CI] of CHD, stroke, and CVD mortality were

deternlined in blacks and whites (Table 2). In Modell, adjusted for age, overweight did
not increase CHD, stroke or CVD mortality in either blacks or whites. However, obesity
increased mortality for all 3 outcomes in whites but not blacks. Given that a previous
report suggested that CVD risk began at higher BMI values for blacks than whites, we
also examined risk associated with more severe obesity, i.e., BMI >35 kg/m 2. In blacks
with BMI >35 kg/m2, C\'D mortality was not significantly greater than in normal weight
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blacks (1.09 [0.89-1.36]).

In contrast CVD mortality tended to increase further (1.51

[1.29 - 1.76]) among whites with BMI >35 kg/m2 .
In Model 2, adjusted for age and smoking status, neither overweight nor obesity
was associated with increased CHD, stroke, or CVD mortality in blacks. In contrast,
overweight increased CHD and CVD mortality in whites and obesity increased mortality
for all three outcomes. In Model 3, adjusted for age, cholesterol, diabetes,

hypertension~

and smoking status, neither overweight in blacks and whites nor obesity in blacks had a
significant effect on CHD, stroke or CVD mortality.

Obesity in whites continued to

significantly increase CHD and CVD mortality but the impact was attenuated. Of note,
after adjusting for age, cholesterol, and diabetes but not for hypertension in whites, the
association of obesity to stroke remained significant (1.36, [1.09-1.69]), and the
association with CHD (1.41, [1.25-1.59]) and CVD (1.41, [1.28-1.54]) was strengthened.
In blacks, there was no significant association of BMI to mortality in Models 1 and 2,
which do not include hypertension as a covariate.
The effects of BMI category on CHD, stroke and CVD morality were also
compared between racial groups. Obesity had a greater effect on CHD (p=0.002), stroke
(p=0.012) and CVD (p<O.OOOOI) in whites than blacks.
T'he gender-race specific effects of overweight and obesity on the relative risk
[950/0 CI] of CHD, stroke, and c\rD mortality were obtained using age-adjusted (Model
1), age and smoking adjusted (Model 2), and age, cholesterol, diabetes, hypertension and

smoking adjusted (Model 3) models (Table 3).

In Modell, Model 2, and Model 3,

overweight in black and white men and women and obesity in black men and women
were not associated with an increase in CHD, stroke or CVD mortality. However, in
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Model 1 and Model 2 obesity was associated with increased CHD, stroke, and CVD
mortality in white men and women. In Model 3, obesity was associated with increased
CHD, and CVD mortality, but not stroke mortality, in white men and women. As noted
earlier for whites, the association between obesity and stroke mortality remained
significant for white women (1.37, [1.02-1.83]) and white men (1.46 [1.02-2.11]) when
hypertension was removed as a covariate from Model 3.
Figure 1 shows the relative risk of CHD, stroke, and C\lD mortality associated
with underweight, overweight, and obese relative to normal weight in blacks and whites
using Model 2, adjusted for age and smoking. For whites, there is a V-shaped pattern
with increased CHD, stroke, and CVD mortality in underweight and obese women and
men than in normal weight and overweight women and men. In blacks, stroke and CVD
mortality were greater in underweight women and men.

In blacks, there was little

difference in CHD mortality associated \vith underweight, overweight and obese
compared to normal weight.

Discussion
Various epidemiological studies have sho'-"'n the association between BMI and

CI-ID. stroke, and CVD mOl1ality to

b~

inconsistent(2-4;9;11;12;15;20;26;39-44). The

variable associatIons between race, BMI, and CVD mortality are likely explained by the
comparatively slnall numbers of black participants included in most of these studies. The
Black Pooling Project was designed to address this limitation. For this report, there are
82,983 person-years of 0Qservation in blacks and 368,069 in whites. Our data suggests
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that there is an association between obesity and

CHD~

stroke, and CVD mortality in

whites but not in blacks.
Obesity was associated with increased CHD, stroke and CVD mortality in whites
after adjusting for age (Modell) and for age and smoking (Model 2). In contrast, obesity
was not associated with increased risk for CHD, stroke, or CVD mortality in blacks. The
association of obesity to CHD and CVD mortality remained significant in whites after
adj ustment for multiple comorbid risk factors (Model 3), whereas the association with
stroke was no longer significant.

Regardless of gender or race, overweight was

associated vvith little difference in risk for CHD, stroke, or CVD mortality.
Our group has previously reported that, 'Nhile blood pressures are greater In
blacks than whites in all BMI categories, BMI is more strongly related to blood pressure
in vvhites than blacks(45). These findings suggest that hypertension is an important factor
by which obesity rnediates adverse cardiovascular effects, especially in whites.
Pa11icularly in whites, it seems appropriate to exclude hypertension as covariate when
assessing the contribution of obesity.
in Model

3~

"'Then excluding hypertension from the covariates

the mean hazard ratios associated "'NIth ob(;sity in whites increase for CHD

(1.21 vs. 1.41), stroke (1.14 vs. 1.16) and CVD (1.18
t~ere wer~

VS.

1.41) mortality. In contrast,

no significant association between obesity and rnortality in black women or

nlen in any of the three models (Table 2).
Obesity had a greater adverse iIupact on CHI), stroke and CVD mortality In
whites than blacks. 'rhese

observation~ ~uggest

that

prev~ntion

and treatInent of obesity

are likely to have greater effects to reduce deaths from heart disease, stroke and
cardiovascular disease in \vhites than blacks. As noted above) the relationShip of obesity
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to stroke iTIortality w'as no longer significant in whites after adjustment for cholesterol,
diabetes, and hypertension. When hypertension 'was excluded from the list of covariates
in Model 3, stroke mortality was 36% higher (9% weight whites.

69~o)

higher in obese than normal

Given the strong association between BMI and blood pressure in

whites( 46), these data suggest that prevention and treatment of obesity would likely
decrease struke as well as CHD and CVD rnortality in whites. Moreover, the number of
':itrokes 'vas comparati vely less than the number of C'HD and total CVD events, which
may also contribute to the absence of a significant association between obesity and stroke
in whItes in Model 3.
In whites, underweight

~wa~

associated with significantly greater risk of CHD

(1.36 [1.06-1.73J) and C:VD (1.38 [1.11-1.69J) but not stroke (1.22 [0.74-2.01]) compared
to normal weight subjects. Among blacks, underweight compared to normal weight was
associated with a significantly higher risk of stroke (2.19 [1.29-3.7]) and CVD (1.79
l1.22-2.62]) bUt not CI-ID (1.05 rO.61-1.811)

~Figure

1).

These findings indicate that

under",-eight is associated with increased CVD mortality in both blacks and whites
There is no significant racial difference in CIID, stroke, or CVD fisk associated with
underweight whleh Inay be explained by the small number of subjects ciassified as
underv-leight.
The results in this analysis indicate that obesity is associated with a significantly
greater risk of CHD, stroke and

(~\TD

mortality in whites but not in blacks. 'Ihis risk is

attenuated when risk factors that are in the causal pathway, especially hypertension. are
included as ccvariates. We did not fine. an Increase in CHI), stroke, or C:VD mortality in
\JveniVeight men and

W(lrrH;:~n

which agrees with some previous studies(39) and disagrees
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with

others(9~47).

Of interest, our study confirms previous reports that underweight is

also associated with increased CVD mortality.in both whites and blacks independently of
cigarette smoking status.
One limitation of this study is the lack of data on body fat pattern, which typically
includes waist circumference and/or waist:hip ratio. Previous reports indicate that a more
centralized or abdominal fat pattern is associated

~vith

increased C\TD mortality(40;48).

Data on waist circumference and/or waist:hip ratio ""ould have allowed a more
comprehensive analysis of the relationship between BMI category and CHD, stroke and
CVD mortali[y. The strength of the Black Pooling Project is the long period of follow up
and substantial sample size of both blacks and whites, which provides a unique
opportunity to exanline associations of BMI and CHD .

stroke~

and

C~\/D

rnortality. BMI

has been highly correlated "'lith waist circumference (r---O.8-0.9)(46), and evidence
sugges~s

that

\\-~aist

circumferences at any B1\11 are similar or less in blacks than

'vvhites(49;50).
Another limitation of the study is that all patient characteristics used as covariates,
including BMI., were obtained only at baseline. For covariates that could change over
t1.me we may not be obtaining a true picture of the cOvariate etTect by adjusting only for
baseline

val~es

HO\ivev~r,

a study of ovel 17,000 rnen and women aged 20-61 years at

baseline that tracked L:ardiovascul&T risk factors over 16 years(Sl) found a high degree of
tracking for BMI (0.85 for men and 0.80 for v,",oInen). This suggests that baseline BMI
can be representative of Bl\tlI later in life and suitable for predicting mortality.
}\dditionally other studies ha"\·e suggested that BMI in early adulthood is positively
related to CVD lTIortality later in life, :hat there 'Nas no association betvveen vveight gain

and later mortality(52) and that. risk associated with excess weight is greater in younger
persons( 53).
These results confirm an association between obesity and CHD, stroke, and CVD
mortality in whites. While the association with stroke was no longer significant in whites
after adjusting for multiple confounders including

hypertension~

pressure are more strongly related in whites than blacks(45).

weight and blood

When hypertension is

removed from the list of covariates in Model 3, obesity is a statistically and clinically
significant risk factor for CHD, stroke and CVD in both white men and -women.
Although obesity is clearly associated ·with diabetes and other health risks in African
Americans~

our study does not show an independent relationship with CHD, stroke and

C\TD rnortaliL) in this ra.cial group. While prevention and treatment of obesity is

recommended for overall health, our findin.gs suggest that weight loss may be more
effective at reducing cardiovascular disease murtality in \vhites than blacks.
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Table 1. Sample size and study characteristics of black and white women and men.

N

CVD Deaths
CHD Deaths
Stroke Deaths
Person-Years
Age
Systolic Blood Pressure
Diastolic Blood Pressure
Cholesterol
Underweight C~~)
Overweight (%)
Obese (g.,~)
Diabetes (%)
Non Smoker (0/0)
Former Smoker (%)
Current Smoker (0/0)

Total
4,853

Black
Womefl
2,843

1165
569
302
82,893
51 1 (14)
148 (32)
91 (16)
220 (48)
3%
33°/1)

636
297
174
50,881
50.1(14)
i49 (34)
90 (16)
223 (49)
4<70
31%

529
272
128
32,012
52.7 (14)
147(29)
92 (16)
216 (46)

260/'0

34~o

60/0

70/'0
66'10
60/0
28%

14%)
5%
36%
130/0
510/0

54?/~

9?/o
37~1c,

78

Men
2,010

30/0
49%

Total
22~838

I

3738
2388
631
368,069
51.3 (14)
134 (23)
83 (12)
224 (48)
3%
34~~

1S%
40/0
460/0
210/0
330/0

White
Women
12,739
1,654
980
343
215,400
50.4 (15)
133 (25)
82 (12)
227(51)
4%
45%
180/0
4°/'0
59~1o
11~o

28°/0

Men
10,099
2,084
1,408
288
152,669
52.4 (14)
136 (21)
85 (12)
221 (45)
2%>
56~/0

13"lo
40/0
29%
3 1~Io
400/0

Table 2. Impact of overweight and nbesity on adjusted* relative risk for CHD, stroke,
and CVD mortality in blacks and \vhites.

OVERWEIGlff

Modell:

Blacks
\Vhites

OBESE

CHD

Stroke

CVD

CHD

Stroke

CVD

0.92
[0.75-1.12]
1.09
[0.99-1.20]

0.81
[0.62-1.08]
0.99
[0.83-1.19]

0.85
[0.74-0.98]
1.06
[0.98-1.14]

1.12
[0.91-1.38]
1.33
[1.19-1.48]

0.81
[0.61-1.09]
1.33
[1.08-1.65]

0.97
[0.84-1.12]
1.34
[1.22-1.46]

0.95
[0 78-1.17]
1.16
(1.05-1.281

0.84
[0.63- 1.13]
1.04
[0.87-1.25]

0.89
[0.77-1.03]
1.12
[1.04-1.201

1.01
[0.81-1.26]
1.50
[1.34-1.69]

0.84
[0.63-1.13]
1.40
[1.12-·1.73]

1.02
[0.88·-1.20]
1.48
[1.35-1.62]

0.88
[0.72-1.09]
1.04
[0.95-1.14]

0.79

1).83
[n 72··0.97]
1.01
[094-1.09J

0.87
[0.69-1.09]
1.21
[1.07-1.36]

0.84
[0.61-1.16]

0.91
[0.77 .. 1.05J
1.18
[1007-1,,29J

Model 2:
Black5
\Vhites
Model 3:
Blacks

[0.5Y- 1.081

0.97
[0.81- 1. 17}

1.14

[091-1 44]
Whites
*Model l adjusted for age
1\1ode12 adjusted for age and slTIoking status
Model 3 adjusted for age, cholesterol~ diabetes, hypertension, and smoking status
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Table 3. Relative Risk of CHD, stroke and CVD mortality associated with overweight
and Obesity in black and white women (upper) and men (lower).

WOMEN

Modell:
Blacks
Whites

CHD

OVERWEIGHT
Stroke

1.09 [0.81-i.47] 0.87 [0 58-1.30]

CVD
090 [0.73- 1

III '

CHD

OBESE
Stroke

CVD

1.21 [0.90-161]

0.98 [0.68-1.43]

1.12 [0.93-1.36]

1.55 [1.32- 1.81]

1.37 [1.04-1.81]

1.52 [1.34-1. 72 ]

1.05 [0.89-1.22]

1.04· [0.81-1 33] 0.98 [0.87-1.10]

1.09 [0.80-1.48]

0.89 [0.58-1.37] 0.92 [0.74-1.14J

1.18 [0.88-1.60]

1.08 [0.73-1.60]

1.14 [0.94-1.39]

1.01 [0.87-1.18]

1JJ9 lO.cl4-1.40]

1.67 [1.42-1.97]

1.42 [1.07-1.60]

1.61 [1.42-1.82]

0.9'7 [0.71-1.32]

0.81 [0.52-1.25] 0.83 [0.66-1.02] : 1.03 [0.76-1.42]

0.96 [0,64-1.45]

1.02 [0.83-1.25]

0.89 [0 76-1.04]

1.01 [0.78-1.31] 0.93 [0.83-1.05] : 1.32 [1.12-1.57]
,,,

1.15 [0.85-1.54]

1.27 [1.12-1.451

Stroke

CVD

Model 2:
Blacks
White8

1.04 [0.93-1.17]

Model 3:
Blacks
Whites

:

CHD

MEN

,

Stroke

CVD

,,

CHD

Modell:
I

Blacks
Whites

0.8'; [0.65-1.12] 0.84 [056-1.25] 0.77 [063·0.93] : 0.94 [0.65-1.34]
1.13 [1.01-1.28]

0.92 [0.71-1. 19]

1.02 [0.93-1.12] :1.32[1.12-1.~4]

0.73 [0.40-1.33] 096 [0.74-] .24]
1.46 (1,04-2.07]

1.32 [1.16-1.51]

0.91 [0.75-1.11] :0.96 [0.65-1.40] 0.74 [0.39-1.40]

0.99 [0,76-1.31]

f'vlodeI2:

o. 92

Blacks
Whiks

[O,69~ 1.22]

1.14 [0.76-1.731

I

1.11 [0.98-1.25]

0.97 [0.'74-1.26]

1.05 (0.95-1.16] : 1.43 [1.21-1.69]

1.50 [1.05-2.14]

0.88 [066-1.19]

0.79 [0.51-1.231

0.87 [0.71-1.08] :0.86 [0.57-1.28

0.65 [0.34-1.25] 0.88 [0.66-1.17

0.99 [0.88-1.13]

0.86 [0.65-1.12]

0.95 [0.86-1.0'5] :1.18 [1.00-1.41]

l.23 [0.85-1.78]

1.42 [1.24-1.63]

Model 3:
Blacks
Whites

*Model 1 adjusted for age
Model 2 adjusted for age and slnoking status
Model 3 adjusted for age~ cholesterol~ diabetes, hypertension, and smoking status
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1.16 [1.01-1.34]

Figure 1. Relative Risk of CHD, stroke and CV"D mortality associated with underweight,
overweight and obesity compared to normal weight in black and whites.
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CHAPTER 4

A paper submitted to Epidemiology

The Association between BMI and CVD Mortality Varies with
l\ge and _Race
Jill E. f\bell, Brent M. Egan., Peter W. F.\Vilson, Stuart Lipsitz, Robert F. Woolson,
l)aniel T. Lackland

Abstract
Background: In previous studies vve have shown that obesity is associated with
increased cardiovascular (CVD) mortality in white women but not in black women.
Earlier research suggests that body mass index (BMI) has a greater effect on CVD
mortality in younger than older whites~ whereas this relationship in blacks is not as clear.
This study examInes the effect of age on the association of BMI to CVD in black and
white

w~)m~n.

Methods: The Black Pooling Project includes data on 2,843 black women with 50,464
person-years of follo\-v-up and 12,739 \Nhite \-vomen with 214,606 person-years of followup. A Cox proportional hazards model was UScG to exarlline the association between BMI
and CVD lTlortality for specific age-race gruups. The younger group was < 60 years and
the older group was> 60 years

(If

age.

Rtsults: In younger whites, the relative risk tor C'/D mortality was significant in obese
(BIvlI >30 kgltn2) ver~us normal weight (BMI 18.5-24.9 kg/m2) \-vomen (1.59[1.20··
2.09]). Similar1y. in older whites. the relative risk for CVD
.

mortalit~r

in obese versus

,

normal weight women was significant (l.21 [1.04-1.41]). There "",'ere no such significant
associations for black women. Overweight (BMI 25-29.9 kgim 2) was net associated with
increased risk iE black or white W{Jinen.

Conclusion:

These findings indicate that \)besity

i~

ass(/ciated with a greater risk of

CVD ITlonahty arnong v!hite but not black '''0[J1('n, ,;vith the strongest association among
v.,'hite

\VOlnen

< 60

year.~.

Introduction
Although obe8ity represents a health risk for most populations, the risk levels
may vary with race, and age. 1 Some studies have found that the risk of cardiovascular
disease (CVD) mortality is associated with a high BMI, 2 that the risk associated with
obesity is greater for whites than blacks 3 and that there is an independent, direct positive
association with BMI even after controlling for variables in the causal pathway.

4

Age impacts the association of body mass and C\lD mortality. Analysis of the

A•.merican Cancer Society's Cancer Prevention Study data found that among men and
wonlen aged 30-74

years~

a greater body weight vias associated with an increased risk of

death from C VD but that the risk associated \\lith excess weight was greater in younger
persons. 5 Data sugge8t that the prevalence vf obesity decreases after age 60 6 and it has
long been questioned vvhether the ideal weight for elderly persons should be greater than
younger persons."7 Obesity also has a profound effect on life expectancy especially
among younger adults. 8 However in blacks~ decreased life expectancy was observed at
hIgher

B~1I

levels t!1an in whites suggesting that high body Inass is not as detrimental in

the black population.
()verweight and obesity is a gro\\ing epidemic and major public health COnCeiTI.
According

try

estlnlutes from

2003-2004~ 62~/O

of US w()men were overweight or obese

(BJ\,lI >25 kg/m2), 33~'O were obese (B~\11 >30 kg/m2) and 7% wele morbidly obese (BMI
>40 kg/m~~).9 The prevalence of ov~rweight and ,)be:~ity varied with age and rar.e.
Overweight and
years) and

old~:r

ob~sitywas

greater in

rniddle~age

(40-59 years) than younger (20-40

(>60 years) Wlnnen and the prevalence was higher

ir~

hlack:5 than whites

In aU age groups fc)r wornen. \Vith the continujng rise in overweight and obesity.

84

particularly in younger adults and children., it has been suggested that this may be the first
generation that will have a shorter lifespan than their parents. 10
In previous studies we have found that obesity is associated \vith CVD mortality
in whites but not in blacks. 11 This analysis examines the effect of age on the association
ofBMI and CVD mortality in black and \\Ihite women.

Methods
Data Source
This stlldy uses data from the Black Pooling Project, which includes subject-level
data fi-oln four studies; Evans County Heart Study, Charleston Heart Study, NHANES I
and NHANES II. The Black Pooling Project \vas established to provide an adequate
number of black

~ubjects

to assess

~ardiovas..:ular

disease risks. Baseline data on 15,582

'women (1,843 Black women and] 2,739 vvThite women) were collected between 1960 and

1980_ FoBow~up on mortality status lasted 15-30 years and includes 265,070 personyears.
In each of the studies, blood preSS1lre, cholesterui, height and weight, diabetes
status and slTIoking status were

meas~red

or collected in a uniforrrl_ manner by trained

personnel. i2-i4 Cause of death was determined from death certific.ates in each study 13-17
ex.cl~pt

I'\) HANES II in vvhich mortality status \vas ascertained solely by computerized

tnatching to national jataba~es and' evaluatIon of the resulting matches. 18 In addition to
death certificates all information gathered in the Evans C:ounty Heart Study pertaining to
death was revievvt!d by a panel of n-Jee physicians and a cardiologist to classify the
deaths. }\ neurologist also r~viewed the information for any evidence of stroke: 6
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Analysis
Sample size, CVD deaths, person-years of follow-up, prevalence of overweight
(BMI 25 .0-29.9kg/m2):. obesity (BMI >30 kg/m2) and other study characteristics were
decermined for each agee-race group. The relative risk (RR) of CVD mortality associated
with overweight and obesity were estimated with a Cox Proportional Hazard Model using
normal weight (BMI 18.5-24.9 kg/m2) as a referent group. Three models, one controlling
for

age~

the second controlling for age and smoking and the third controlling for

age~

hypertension, cholesterot diabetes and smoking status vvere run separately 'Nithin the
age-race groups in each of the four cohorts. Data were pooled using subject-level metaanalysis to obtain an overall estimate. The

covariat~s

priori. Model 1 provides a crude age-adjusted

in each model were selected a

me~sure

of risk. Model 2 controls for age

and smoking; smoking is a common covariate because of its association with weight.
fvlodel 3 adjusted for age. hypeltensivn. total cholesterol, dIabetes and smoking status to
test for associations between BrvfI and C\lD ITlortallty after controlling for known
cardiovascular ri~k factors.
Subject-level meta-analysis was used to calculate the overall estirnate of the

wei.ght effect. SubJect-level rneta-analysis

~nvolves

the reanalysis of subject-level data

providing a reliable rnc&ns of addressing questions not

satisfil~torily

resolved in

indi vidual studies. I c;-?~. '{'his method is a fnore st~nsiljve analysis than typical study-level
nleta-analysis fOUild in the

liter~turt;.

The rIsk factor

co~fficients

obtaIn (;\ pooled

coeffici~nt.

for each

age-{a(~t'

For each study, age and race group a Inodel "vas fit.

from the individual regression models

~Tere

then conlbined to

The pooled coefficients comprise the pooled risk equation

gr0up. Both fixed and random effects models were used to obtaifl. the
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pooled risk equation. Since the results from the fixed effect model were generally
consistent with the results from the random effects model, only the results from the fixed
effect model are reported.

Results
The prevalence of obesity in black and white women in 10-year age-groups is
presented in Figure 1. The prevalence of obesity in black women increased from 22% in
those younger than 30 years to 42 e/o in those age 50-60 years ..After age 60, the
prevalence of obesity began to del.;line and among those: older than 70 years

26~,tQ

were

classifIed as obese, Among w-hite women, obesity prevalence increased from 11 % in
thos~

younger than 30 years to 21 ~/o in 50-60 year ()lds. After age 60 the prevalence of

()besity relnaii'led constant in white \\-'omen rather than decreasing as was seen in biack
WOlllen.
'I able 1 presents sample

size~

C\lD deaths, person-years of follow-up~ mean and

prevalence of study characteristics for

~/ounger

«60 years) and older (>60 years) black

and white wonlen. The prevalence of o'verweight, obesity, hypertensi(ln and diahetes is
greater in hlack than white \vnmen and incn;ases wi:h

agt~.

Current smoking was more

prev[!.len( in whites and decreased with age,
I'he relative

n~k

of CTvI) mortality

8.s30cia~ed

with

B~11

(overweight and obese),

compare,d LO norrnal \\.ieight was calculated for each age-race group in each of the four
studies; and pooled using

m~ta-analysi:-;

<Tabje 2). There ,vas little or no

6~k asso~iated

'with-()ver\\,ielght compared to norma'! \veight in any of the four age-race groups. .L\mong
obese 'women there "01as a significant

aS50ciat~on
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'Vvith CV'D mortality in younger and

older white women in Model·1~ Model 2J and Model :3 and for younger black women in
Modell and Model 2 but not in Model 3. The association between obesity and CVD
mortality was significantly greater- in younger than older whites in Modell (2.12 [1.642.74] vs. 1.38 [1.20-1.59], p-value 0.013) and in Model 2 (2.49 [1.91-3.22] vs. (1.44
[1,25-1.65], p-value 0.002). The association between obesity and CVD mortality was
greater for younger than older white women in Model 3 (1.59 [1.20-2.11] vs.1.21 ([1.041.41], p-value 0.126), but the difference was not significant. Obesity was associated with
CVD mortality in younger but not older black women in Modell (1.39 [1.03-1.90] vs.
0.99 [0.77-1.33J) and Model 2 (1.46 [1.07-2.01] vs. 1.18 [0.90-1.55]). Obesity was
associated with CVD mortality in neither younger nor older black women in Model 3
(1.23 [0.90-1.70] vs. 0.99 [0.75-1.33]).
The association between obesity and CVD mortality was stronger in white than
black women. This association was significantly greater in younger white than younger
black women in Modell (2.12 rl.64-2.74] vs. 1.39 [1.03-1.90], p-value 0.04) and in
Model 2 (2.49 [1.91-3.22] vs. 1.46 [1.07-2.01], p-value 0.012). The racial differences
were n9t tested in Model 3 since the CVD mortality risk was not significant for younger
black women.
Discussion
In previous research, ,Me found that obesity is associated with Increased CVD
TI10rtality in white women but not black women. 11 This study extends the previous
reports by documenting that obesity is associated with an increased risk of C\lD
Jnortality in bot.h younger and oider white women Among white

women~

the association

between obesity and C\TD alortality is stronger in younger than older subjects. In black

wonlen, there was an association between CVD mortality and obesity in younger but not
older women; however this association ,vas only significant in Modell, controlling for
age and Model 2, controlling for age and smoking status. The association between
obesity and CVD mortality was no longer significant in Model 3, which controlled for
hypertension, total cholesterol, and diabetes in addition to age and smoking status. The
results 0f Model 3 suggest that the increased CVD mortality risk in younger obese black
women is mediated in part by risk factors associated with obesIty. Overweight was not
associated with C:\7[) mortality in any age-race group.
These results suggest that the prevention and treatment of obesity would have the
greatest irnpact on reducing total cardiovascular mortality in white women, especially
those younger than 60 ytars. \\'hile there was a significant association between obesity
and CVD

mo~tality

in both younger and older white women, the association was stronger

in younger women. The observation that obesity is more strongly associated with CVD
mortality in younger persons is consistent with previous findings. For instance, the
Cancer Prevention Study found that elevated BMI was associated with increased CVD
deaths but that the risk

W:lS

greater in younger persons. 5 In a historical cohort of men

with a mean fnHow-up of 35 years, a strong signIficant association was found hetvveen
Brvtl in y{)ung adulthood and CVI) mortality (HR 2.41) and a weaker,

non-signifi~ant

asso~iation for Bl\1I jn mid-adulthood (HR 1.33 ).25 In a prospective study of 6~ 193

obese patients.,

th~

risk of death increased vlith body vtleight, but obesity-related excess

nlortality dcc.iined "with age at all levels of mortality. 26 A report from the Longitudinal
Study of A.ging suggested that

ob(~sity

ffiIf.,ht be protective in older community dwelling

A.rnericans conlpared to being thin or of nornlal 'Neight. 27 I'he lack of association

between CVD mortality and overweight in blacks and whites and obesity in blacks is also
consistent with previous findings.2~11 In the present study, this lack of association
between overweight and CVD mortality persists among both younger and older subjects.
The suggestion that an increased body mass affects people differently is not a
novel idea. There has long been the discussion that the ideal weight for elderly persons
should be greater than younger persons, 7 and it has been shown that after age 60 the
prevalence of obesity decreases. 6 One explanation for this phenomenon includes
selective survival, where obese young and middle-aged persons die prematurely. A
second possible explanation is a cohort effect, where older persons come from cohorts
that typically were not obese or that body fat is redistributed with increasing age. 6 It is
also possible that older subjects, even at a normal BMI, have less lean mass and .more
adiposity which raises their CVD risk closer to levels of the obese. In this study, the
prevalence of obesity peaked between 50-60 years in black women and then began to
decline. H{)w-ever in white women, the'prevalence of obesity peaked at 50-60 years and
then remained constant across the older age groups.
One of the limitations in this study is that all study characteristics were collected
only at baseline. We do not have additional measures of the covariates to assess whether
weight or other risk factor changes during the 15 to 30 years of follow-up might have
affected the results. However it has been suggested in a study of men, that BMI in early
adulthood is positively related to CVD mortality later in life and that an association
between weight gain and later mortality was not found 25 . Although that study focused on
men and not women, the results suggest that weight early in life might be a better
predictor of CVD mortality than multiple measures or measures later in life. Another
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limitation to this study is the lack of data on waist circumference, a commonly used
measure of visceral fat. Previous reports indicate that a more centralized or abdominal fat
pattern is associated with increased CVD mortality.28 Data on waist circumference may
have allowed a more comprehensive analysis of the association between BMI and CVD
mortality. However BMI has been found to be highly correlated with waist
circumference (r--0.8-0.9),29 and evidence suggests that waist circumferences at any BMI
are similar or less in blacks than whites. 30 ;31
These results suggest that there is an association between obesity and CVD
mortality in younger and older white women. Among white women obesity is associated
with a greater CVD mortality risk in women younger than 60 years of age. This is
particularly important as the prevalence of obesity in children and younger adults being
classified as overweight and obese continues to increase. As the prevalence of obesity
increases in younger women it is reasonable to assume that the number of women at
increased risk of CVD mortality will also increase. Hence, obesity treatment and
prevention would most likely have the greatest Impact on reducing CVD mortality in
white \-vomen, particularly those under age 60. While obesity was not independently
associated with CVD mortality in blacks, a significant association in younger black
women was observed until adjustment was made for obesity-associated risk factors
including hypertension and diabetes. Since medical management of risk factors can be
suboptimal, weight loss, which improves multiple cardiovascular risk factors, is likely to
reduce cardiovascular mortality in younger black women. Given non-cardiovascular
health risks of obesity, which include degenerative joint disease and several cancers, the
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treatment and prevention of obesity in all women has important personal and public
health implications.
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Figure 1. Obesity prevalence by age group in black and white women
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Similarly, obesity was associated with CHD, stroke and CVD mortality
differently for blacks and whites. Like blood pressure~ CHD, stroke CVD mortality was
more highly associated with obesity in white men and women than in black men and
women suggesting mechanisms independent of body mass.
Future research should also focus on the translation of these results to clinical
practice. While our research suggests that weight loss affects blood pressure and
cardiovascular mortality differently in blacks and whites, weight loss intervention studies
that inc1ude both blacks and \\-'hites should be conducted to truly understand these results.
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